Tag: Novartis Oncology

High Grade Neuroendocrine Cancers Guide, Healing NET Foundation 2021_2

New Guide on High-Grade Neuroendocrine Cancers

November 9, 2021

Have you or a loved one been diagnosed with high-grade neuroendocrine cancer?  There’s a new guide for patients and caregivers, just released by the Healing NET Foundation in observance of NET Cancer Awareness Day, November 10, 2021.  Healing NET worked…

READ MORE
Lisa Yen, LACNETS

Lisa Yen Selected as 2020 Monica Warner Award Recipient

May 27, 2021

Congratulations to Lisa Yen, NP, NBC-HWC, of LACNETS upon being selected as the 2020 Monica Warner Award recipient! The award, established by Novartis Oncology in 2009, is presented annually to “honor a patient, supporter, or caregiver who most embodies…

READ MORE
Monica Warner Award_3

2020 Monica Warner Award: Call for Nominations

December 10, 2020

Advanced Accelerator Applications (AAA), a Novartis company, has announced that nominations are open for the 11th Annual Monica Warner Award!  AAA is continuing the Novartis tradition of sponsoring the award, which commemorates the life and work of…

READ MORE
MonicaWarner(2)

8th Annual Warner Advocacy Award: Call for Nominations

November 14, 2017

Novartis Oncology and The NET Alliance have announced that nominations are open for the 8th Annual Warner Advocacy Award. This annual award was established by Novartis in 2009 in honor of Monica Warner, who passed away in August 2009, to recognize …

READ MORE
MonicaWarner(2)

Call for Nominations: 7th Annual Warner Advocacy Award

November 17, 2016

Novartis Oncology and The NET Alliance have announced that nominations are open for the 7th Annual Warner Advocacy Award. This annual award was established by Novartis in 2009 in honor of Monica Warner, who passed away in August 2009, to recognize the …

READ MORE
Warner Advocacy Award 2015_Deadline for Submissions

Call for Nominations: 6th Annual Warner Advocacy Award

July 30, 2015

Do you know someone who is a passionate advocate for patients with neuroendocrine tumors (NETs)? Novartis Oncology and The NET Alliance are searching for an outstanding NET patient advocate to recognize and honor with the 6th Annual Warner Advocacy

READ MORE
Immunotherapy Researchers, June, Hu, Kunz

10 Highlights of the Year 2014 for the Carcinoid and Neuroendocrine Tumor Community

December 18, 2014

As the Carcinoid Cancer Foundation looks back on the year 2014, we reached out to physicians, patients, support group leaders, listserv managers, patient advocates, and business colleagues to see what they thought were among the highlights of the past…

READ MORE
Warner Advocacy Award 2014, Call for Nominations

Call for Nominations: 2014 Warner Advocacy Award

June 6, 2014

Do you know someone who is a passionate advocate for patients with neuroendocrine tumors (NETs)? The NET Alliance™ and Novartis Oncology have announced the 2014 Warner Advocacy Award, named in honor of the late Monica Warner, a driving force behind the…

READ MORE
Sandostatin, Celebrating 25 Years of Commitment

Novartis Offers New Sandostatin LAR Depot Co-Pay Assistance Program

March 31, 2014

A new co-pay assistance program for carcinoid syndrome patients taking Sandostatin® LAR Depot has been established by Novartis Pharmaceuticals Corporation, effective February 2014.

With the Sandostatin® LAR Depot Co-Pay Assistance Program, eligible…

READ MORE

New Jersey Carcinoid Cancer NETwork Conference Videos Now Available

January 19, 2014

Carcinoid and neuroendocrine tumor (NET) patients, physicians, caregivers, support group leaders and patient advocates gathered to learn more from nationally and internationally recognized carcinoid/NET specialists and local physician specialists…

READ MORE